Combined Study - Phase 3b MenB Long Term Persistence in Adolescents

Clinical trial NCT02446743 · COMPLETED

Trial details

NCT number: NCT02446743
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Meningococcal

Start date: 2015-11-17
Primary completion: 2016-09-23
Enrollment: 531

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.